College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK.
Department of Urology, Pilgrim Hospital, United Lincolnshire NHS Trust, England, UK.
Scott Med J. 2023 Feb;68(1):4-13. doi: 10.1177/00369330221134233. Epub 2022 Dec 28.
Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.
Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).
Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%, < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00, < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53, = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40, = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes ( and ) between primary UTUC and subsequent UBR.
Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.
根治性肾输尿管切除术(RNUx)后发生的尿路上皮膀胱癌(UBR)是上尿路尿路上皮癌(UTUC)患者面临的一个已知挑战。本研究旨在评估与 UBR 相关的因素以及与切除的 UTUC 的克隆相关性。
确定了 1998 年至 2015 年在五个机构接受 RNUx 治疗的 UTUC 患者。在一个亚组中,使用下一代测序评估原发性 UTUC 和随后的 UBR 之间的克隆相关性。采用 Kaplan-Meier 曲线评估两组(行或不行输尿管镜活检)之间 UBR 的差异。
在有完整记录的 267 例患者中,73 例(27.3%)在随访期间发生 UBR。所有患者的 5 年 UBR 无复发生存率为 64.7%。与未行输尿管镜活检的患者相比,行输尿管镜活检的患者 5 年 UBR 无复发生存率更差(49.9%比 76.4%, < 0.001)。膀胱癌病史(HR,95%CI;2.94,1.73-5.00, < 0.001)、输尿管镜活检(HR,95%CI;2.21,1.38-3.53, = 0.001)和术前尿细胞学≥C3(HR,95%CI;2.06,1.24-3.40, = 0.005)与 UBR 独立相关。行输尿管镜活检的患者(n=3/5)在原发性 UTUC 和随后的 UBR 之间显示出常见基因(和)相同的突变变化。
UTUC 的输尿管镜活检是 UBR 的一个重要危险因素。定性克隆性评估显示原发性 UTUC 和 UBR 之间存在相同的突变特征。